A New Germline TP53 Gene Mutation in a Family With Li-Fraumeni Syndrome

By Dockhorn-Dworniczak B.   Wolff J.   Poremba C.   Schafer K.-L.   Ritter J.   Gullotta F.   Jurgens H.   Bocker W.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1359-1365

Elsevier

Access to resources Recommend Favorite

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

By Masciari Serena  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1125-1130

Springer Publishing Company

Access to resources Recommend Favorite

The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds

By Siddiqui Rina   Onel Kenan   Facio Flavia   Nafa Kedoudja   Diaz Louis   Kauff Noah   Huang Helen   Robson Mark   Ellis Nathan   Offit Kenneth  

Familial Cancer, Vol. 4, Iss. 2, 2005-06 ,pp. : 177-181

Springer Publishing Company

Access to resources Recommend Favorite

Potential of Advexin^®®: a p53 gene-replacement therapy in Li––Fraumeni syndrome

By Nemunaitis Jackie M   Nemunaitis John  

Future Oncology, Vol. 4, Iss. 6, 2008-12 ,pp. : 759-768

Future Medicine

Access to resources Recommend Favorite

The MDM2 285G–309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome

By Renaux-Petel Mariette   Sesboüé Richard   Baert-Desurmont Stéphanie   Vasseur Stéphanie   Fourneaux Steeve   Bessenay Emilie   Frébourg Thierry   Bougeard Gaëlle  

Familial Cancer, Vol. 13, Iss. 1, 2014-03 ,pp. : 127-130

Springer Publishing Company

Access to resources Recommend Favorite